Long-term efficacy and safety of canakinumab through 168 weeks in Japanese patients with Schnitzler syndrome: Extended follow-up of the SCan study

Allergology International · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles